Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Oct 08, 2021

BUY
$7.41 - $10.99 $3,705 - $5,495
500 Added 14.29%
4,000 $17,000
Q2 2021

Jul 14, 2021

SELL
$6.35 - $10.0 $9,525 - $15,000
-1,500 Reduced 30.0%
3,500 $22,000
Q1 2021

Apr 14, 2021

BUY
$7.03 - $16.51 $9,842 - $23,114
1,400 Added 38.89%
5,000 $29,000
Q4 2020

Feb 12, 2021

BUY
$5.76 - $11.95 $20,736 - $43,020
3,600 New
3,600 $13,000

Others Institutions Holding SRNE

About Sorrento Therapeutics, Inc.


  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track Collective Family Office LLC Portfolio

Follow Collective Family Office LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Collective Family Office LLC, based on Form 13F filings with the SEC.

News

Stay updated on Collective Family Office LLC with notifications on news.